NO2120568T3 - - Google Patents

Info

Publication number: NO2120568T3
Authority: NO; Norway

Application number

NO08730048A

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-16

Filing date

2008-02-15

Publication date

2018-04-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39690832&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2120568(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-15 Application filed filed Critical

2018-04-14 Publication of NO2120568T3 publication Critical patent/NO2120568T3/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Dispersion Chemistry (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Hematology (AREA)
Diabetes (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)

NO08730048A 2007-02-16 2008-02-15 NO2120568T3 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US90177207P	2007-02-16	2007-02-16
US96519607P	2007-08-17	2007-08-17
PCT/US2008/054168 WO2008101214A2 (en)	2007-02-16	2008-02-15	Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders

Publications (1)

Publication Number	Publication Date
NO2120568T3 true NO2120568T3 (sl)	2018-04-14

Family

ID=39690832

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO08730048A NO2120568T3 (sl)	2007-02-16	2008-02-15

Country Status (20)

Country	Link
US (2)	US8092828B2 (sl)
EP (3)	EP3300601B1 (sl)
JP (1)	JP5314600B2 (sl)
KR (2)	KR20100014441A (sl)
CN (1)	CN105998046A (sl)
AU (1)	AU2008216083B2 (sl)
CA (1)	CA2678332C (sl)
CY (1)	CY1119631T1 (sl)
DK (2)	DK3300601T3 (sl)
ES (2)	ES2650167T3 (sl)
FR (1)	FR22C1034I2 (sl)
HK (1)	HK1253378A1 (sl)
HR (1)	HRP20220428T3 (sl)
HU (2)	HUE058334T2 (sl)
NL (1)	NL301185I2 (sl)
NO (1)	NO2120568T3 (sl)
PL (2)	PL2120568T3 (sl)
PT (2)	PT2120568T (sl)
SI (1)	SI3300601T1 (sl)
WO (1)	WO2008101214A2 (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100075937A1 (en) *	2008-09-24	2010-03-25	Hollis-Eden Pharmaceuticals, Inc.	Patient populations and treatment methods
EP2768484B1 (en)	2011-10-21	2019-07-24	Jazz Pharmaceuticals Research LLC	Lyophilized liposomes
US20140154304A1 (en) *	2012-11-30	2014-06-05	Boehringer Ingelheim International Gmbh	Combination therapy with volasertib
WO2015127173A1 (en) *	2014-02-20	2015-08-27	Agios Pharmaceuticals, Inc	Therapeutically active compounds and their methods of use
WO2015127172A1 (en) *	2014-02-20	2015-08-27	Agios Pharmaceuticals, Inc.	Therapeutically active compounds and their methods of use
IL292080B1 (en)	2015-11-11	2024-05-01	Celator Pharmaceuticals Inc	Treatment regimens for hematological cancers and methods for their use
US11504347B1 (en)	2016-07-22	2022-11-22	Flamel Ireland Limited	Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en)	2016-07-22	2023-03-14	Flamel Ireland Limited	Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es)	2016-07-22	2017-11-30	Flamel Ireland Ltd	Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US11986451B1 (en)	2016-07-22	2024-05-21	Flamel Ireland Limited	Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en)	2016-07-22	2023-03-14	Flamel Ireland Limited	Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
WO2019023873A1 (zh) *	2017-07-31	2019-02-07	江苏竞诺择生物医药科技有限公司	一种用于治疗造血***增殖性疾病的纳米脂质微粒组合物及药用组合物
CN113164502A (zh) *	2018-09-25	2021-07-23	塞拉特药物股份有限公司	血液病的低强度治疗
JP2022522270A (ja)	2019-03-01	2022-04-15	フラメルアイルランドリミテッド	食事摂取状態における改善された薬物動態を有するガンマ－ヒドロキシ酪酸塩組成物
US11980636B2 (en)	2020-11-18	2024-05-14	Jazz Pharmaceuticals Ireland Limited	Treatment of hematological disorders
US11779557B1 (en)	2022-02-07	2023-10-10	Flamel Ireland Limited	Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en)	2022-02-07	2023-02-21	Flamel Ireland Limited	Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7850990B2 (en)	2001-10-03	2010-12-14	Celator Pharmaceuticals, Inc.	Compositions for delivery of drug combinations
CA2383259A1 (en) *	2002-04-23	2003-10-23	Celator Technologies Inc.	Synergistic compositions
KR20050072790A (ko) *	2002-11-06	2005-07-12	셀진 코포레이션	골수증식 질환의 치료 및 관리를 위한 선택적 시토킨 억제약물의 사용 방법 및 이를 포함하는 조성물
US20040152632A1 (en) *	2002-11-06	2004-08-05	Wyeth	Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome
AU2002348178A1 (en) *	2002-11-06	2004-06-03	Wyeth	Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome
EP1744764B1 (en) *	2004-04-22	2012-05-30	Celator Pharmaceuticals, Inc.	Liposomal formulations of anthracycline agents and cytidine analogs
SE0402025D0 (sv) *	2004-08-13	2004-08-13	Active Biotech Ab	Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
EP1976485A4 (en)	2005-12-22	2011-10-26	Celator Pharmaceuticals Inc	LIPOSOMAL FORMULATIONS COMPRISING SECONDARY AND TERTIARY AMINES AND METHODS FOR THE PREPARATION OF SAID FORMULATIONS

2008
- 2008-02-15 PT PT87300489T patent/PT2120568T/pt unknown
- 2008-02-15 HR HRP20220428TT patent/HRP20220428T3/hr unknown
- 2008-02-15 CN CN201610324431.2A patent/CN105998046A/zh active Pending
- 2008-02-15 KR KR1020097019393A patent/KR20100014441A/ko active Application Filing
- 2008-02-15 JP JP2009550160A patent/JP5314600B2/ja active Active
- 2008-02-15 ES ES08730048.9T patent/ES2650167T3/es active Active
- 2008-02-15 PL PL08730048T patent/PL2120568T3/pl unknown
- 2008-02-15 PT PT172004988T patent/PT3300601T/pt unknown
- 2008-02-15 HU HUE17200498A patent/HUE058334T2/hu unknown
- 2008-02-15 EP EP17200498.8A patent/EP3300601B1/en active Active
- 2008-02-15 US US12/032,583 patent/US8092828B2/en active Active
- 2008-02-15 ES ES17200498T patent/ES2909903T3/es active Active
- 2008-02-15 DK DK17200498.8T patent/DK3300601T3/da active
- 2008-02-15 US US12/526,930 patent/US20100303895A1/en not_active Abandoned
- 2008-02-15 NO NO08730048A patent/NO2120568T3/no unknown
- 2008-02-15 EP EP08730048.9A patent/EP2120568B1/en not_active Revoked
- 2008-02-15 PL PL17200498T patent/PL3300601T3/pl unknown
- 2008-02-15 AU AU2008216083A patent/AU2008216083B2/en active Active
- 2008-02-15 CA CA2678332A patent/CA2678332C/en active Active
- 2008-02-15 EP EP22150734.6A patent/EP4046640A1/en active Pending
- 2008-02-15 KR KR20157007810A patent/KR20150038752A/ko active Search and Examination
- 2008-02-15 SI SI200832194T patent/SI3300601T1/sl unknown
- 2008-02-15 WO PCT/US2008/054168 patent/WO2008101214A2/en active Application Filing
- 2008-02-15 DK DK08730048.9T patent/DK2120568T3/en active
2017
- 2017-11-29 CY CY20171101251T patent/CY1119631T1/el unknown
2018
- 2018-10-03 HK HK18112675.7A patent/HK1253378A1/zh unknown
2022
- 2022-07-05 FR FR22C1034C patent/FR22C1034I2/fr active Active
- 2022-07-05 NL NL301185C patent/NL301185I2/nl unknown
- 2022-07-07 HU HUS2200032C patent/HUS2200032I1/hu unknown

Also Published As

Publication number	Publication date
EP3300601B1 (en)	2022-01-12
EP3300601A1 (en)	2018-04-04
JP5314600B2 (ja)	2013-10-16
DK2120568T3 (en)	2017-12-11
PL3300601T3 (pl)	2022-05-02
FR22C1034I1 (fr)	2022-09-09
WO2008101214A3 (en)	2008-11-20
AU2008216083B2 (en)	2014-02-06
KR20150038752A (ko)	2015-04-08
CA2678332A1 (en)	2008-08-21
JP2010519224A (ja)	2010-06-03
EP2120568A4 (en)	2010-04-21
AU2008216083A2 (en)	2009-09-24
PT2120568T (pt)	2017-12-04
NL301185I2 (nl)	2022-07-21
AU2008216083A1 (en)	2008-08-21
US8092828B2 (en)	2012-01-10
FR22C1034I2 (fr)	2023-06-30
PL2120568T3 (pl)	2018-03-30
WO2008101214A2 (en)	2008-08-21
DK3300601T3 (da)	2022-03-21
SI3300601T1 (sl)	2022-05-31
EP4046640A1 (en)	2022-08-24
HUE058334T2 (hu)	2022-07-28
PT3300601T (pt)	2022-04-21
CN105998046A (zh)	2016-10-12
CA2678332C (en)	2015-06-02
HRP20220428T3 (hr)	2022-05-27
EP2120568B1 (en)	2017-11-15
HK1253378A1 (zh)	2019-06-14
ES2650167T3 (es)	2018-01-17
CY1119631T1 (el)	2018-04-04
US20100303895A1 (en)	2010-12-02
ES2909903T3 (es)	2022-05-10
EP2120568A2 (en)	2009-11-25
HUS2200032I1 (hu)	2022-07-28
US20080199515A1 (en)	2008-08-21
KR20100014441A (ko)	2010-02-10

Publication	Publication Date	Title
NO2120568T3 (sl)	2018-04-14
CN300729479S (zh)	2008-01-09	包装盒
CN300730665S (zh)	2008-01-09	烛台(167)
CN300729609S (zh)	2008-01-09	包装袋
CN300904329S (zh)	2009-04-08	电视机(a259)
CN300879522S (zh)	2009-01-28	升降杆(tb1100)
CN300726124S (zh)	2008-01-02	牙刷(钻石镶嵌)
CN300726281S (zh)	2008-01-02	墙纸(23)
CN300726330S (zh)	2008-01-02	沙发(711a)
CN300848139S (zh)	2008-11-12	吊扇叶(yd-a)
CN300838044S (zh)	2008-10-15	包(7d20421)
CN300726512S (zh)	2008-01-02	侧装西裤架(f23)
CN300827961S (zh)	2008-09-10	插头(cm-01)
CN300826548S (zh)	2008-09-10	花架(6x01)
CN300814505S (zh)	2008-08-13	椅子(折叠)
CN300794467S (zh)	2008-06-25	竹砧板(hb0138)
CN300762616S (zh)	2008-04-02	金属休闲凉亭
CN300755543S (zh)	2008-03-19	皮箱(沃森小箱棕白毛皮)
CN300748539S (zh)	2008-02-20	传统式浴柜(3)
CN300732136S (zh)	2008-01-16	食品桶
CN300732052S (zh)	2008-01-16	包装盒(增氧活水器)
CN300731803S (zh)	2008-01-16	玻璃钻
CN300731680S (zh)	2008-01-16	纯银保健杯(花开富贵)
CN300731585S (zh)	2008-01-16	组合柜(c306a)
CN300731569S (zh)	2008-01-16	电视柜(明清风月1850)